These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38309472)

  • 1. In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Lim T; Rajoriya S; Kim B; Natasha A; Im H; Shim HS; Yoo J; Kim JW; Lee EW; Shin HJ; Kim SH; Kim WK
    Virus Res; 2024 Apr; 342():199325. PubMed ID: 38309472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
    Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.
    Son J; Huang S; Zeng Q; Bricker TL; Case JB; Zhou J; Zang R; Liu Z; Chang X; Darling TL; Xu J; Harastani HH; Chen L; Gomez Castro MF; Zhao Y; Kohio HP; Hou G; Fan B; Niu B; Guo R; Rothlauf PW; Bailey AL; Wang X; Shi PY; Martinez ED; Brody SL; Whelan SPJ; Diamond MS; Boon ACM; Li B; Ding S
    mBio; 2022 Feb; 13(1):e0337721. PubMed ID: 35038906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.
    Limonta D; Dyna-Dagman L; Branton W; Mancinelli V; Makio T; Wozniak RW; Power C; Hobman TC
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0049121. PubMed ID: 34001511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
    Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
    Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating.
    Kumar U; Fox CR; Kolanthai E; Neal CJ; Kedarinath K; Fu Y; Marcelo E; Babu B; Parks GD; Seal S
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40659-40673. PubMed ID: 36004755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
    Marlin R; Desjardins D; Contreras V; Lingas G; Solas C; Roques P; Naninck T; Pascal Q; Behillil S; Maisonnasse P; Lemaitre J; Kahlaoui N; Delache B; Pizzorno A; Nougairede A; Ludot C; Terrier O; Dereuddre-Bosquet N; Relouzat F; Chapon C; Ho Tsong Fang R; van der Werf S; Rosa Calatrava M; Malvy D; de Lamballerie X; Guedj J; Le Grand R
    Nat Commun; 2022 Aug; 13(1):5108. PubMed ID: 36042198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
    Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses.
    Garcia G; Irudayam JI; Jeyachandran AV; Dubey S; Chang C; Castillo Cario S; Price N; Arumugam S; Marquez AL; Shah A; Fanaei A; Chakravarty N; Joshi S; Sinha S; French SW; Parcells MS; Ramaiah A; Arumugaswami V
    Cell Rep Med; 2023 May; 4(5):101024. PubMed ID: 37119814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation.
    Straková P; Bednář P; Kotouček J; Holoubek J; Fořtová A; Svoboda P; Štefánik M; Huvarová I; Šimečková P; Mašek J; Gvozdev DA; Mikhnovets IE; Chistov AA; Nikitin TD; Krasilnikov MS; Ustinov AV; Alferova VA; Korshun VA; Růžek D; Eyer L
    Virus Res; 2023 Sep; 334():199158. PubMed ID: 37339718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
    Geraghty RJ; Aliota MT; Bonnac LF
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33924302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
    Kaur R; Tada T; Landau NR
    mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches.
    Brai A; Trivisani CI; Poggialini F; Pasqualini C; Vagaggini C; Dreassi E
    J Med Chem; 2022 Aug; 65(15):10195-10216. PubMed ID: 35899912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
    Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
    mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.